Stanislav Dikiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stanislav Dikiy has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Y. Rudensky
Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, USA
12 shared publications - Alejandra Mendoza
Scripps Research
4 shared publications Andrew G. Levine
Howard Hughes Medical Institute and Immunology Program, Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, USA
3 shared publicationsAriella Glasner
Howard Hughes Medical Institute and Immunology Program, Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, USA
3 shared publicationsMichail Schizas
Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA
3 shared publications- Paolo Giovanelli
Associate Professor of Microbiology and Immunology Well Cornell Medicine New York NY
3 shared publications
Latest Publications
- Open Access
Pharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation
T helper 17 (TH17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of TH17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of TH17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating TH17 cells and demonstrate that its pharmacological activation suppresses TH17 differentiation, highlighting a potential therapeutic strategy for limiting TH17-driven inflammatory diseases.
Open AccessPharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation
T helper 17 (TH17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of TH17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of TH17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating TH17 cells and demonstrate that its pharmacological activation suppresses TH17 differentiation, highlighting a potential therapeutic strategy for limiting TH17-driven inflammatory diseases.
- Open Access
Metabolically Activated Proteostasis Regulators Reduce Differentiation of CD4 + T H 17 Cells
The differentiation of naïve CD4 + T cells into effector T cell subsets such as T H 1, T H 2, T H 17 and T REG cells is governed by tightly coordinated activation programmes dependent on T cell receptor (TCR) engagement, co-stimulation, and cytokine signalling. This differentiation process involves regulation of stress-responsive signalling pathways such as the unfolded protein response (UPR) and the oxidative stress response (OSR) to adapt to the physiologic demands specific to distinct T cell subset functions. This suggests that pharmacologically targeting stress-responsive pathways offers a unique opportunity to selectively remodel the differentiation of these different T cell subsets. We previously identified compound AA147 as a metabolically activated proteostasis regulator that can induce both the ATF6 signalling arm of the UPR and, in certain cell types, the NRF2-regulated arm of the OSR.(Paxman et al., 2018; Plate et al., 2016) Here, we show that treatment with AA147 selectively reduces differentiation of pro-inflammatory T H 17 cells by promoting degradation of the lineage-specifying transcription factor RORγt, without impacting the transcription factors of other CD4 + T cell subsets. We find that AA147-dependent reduction in T H 17 differentiation is independent of ATF6 activation but involves NRF2 activation and reductions in intracellular reactive oxygen species (ROS). Apart from RORγt, we further show that AA147 decreases expression of the TCR-responsive factor IRF4, thus suppressing production of select effector cytokines across effector T cells, revealing additional ways in which this compound reshapes the activities of these essential T cell subsets. Our results demonstrate the potential for metabolically activated proteostasis regulators such as AA147 to selectively reshape T H 17 cell identity while broadly dampening effector cytokine responses across effector T cell subsets.
Open AccessMetabolically Activated Proteostasis Regulators Reduce Differentiation of CD4 + T H 17 Cells
The differentiation of naïve CD4 + T cells into effector T cell subsets such as T H 1, T H 2, T H 17 and T REG cells is governed by tightly coordinated activation programmes dependent on T cell receptor (TCR) engagement, co-stimulation, and cytokine signalling. This differentiation process involves regulation of stress-responsive signalling pathways such as the unfolded protein response (UPR) and the oxidative stress response (OSR) to adapt to the physiologic demands specific to distinct T cell subset functions. This suggests that pharmacologically targeting stress-responsive pathways offers a unique opportunity to selectively remodel the differentiation of these different T cell subsets. We previously identified compound AA147 as a metabolically activated proteostasis regulator that can induce both the ATF6 signalling arm of the UPR and, in certain cell types, the NRF2-regulated arm of the OSR.(Paxman et al., 2018; Plate et al., 2016) Here, we show that treatment with AA147 selectively reduces differentiation of pro-inflammatory T H 17 cells by promoting degradation of the lineage-specifying transcription factor RORγt, without impacting the transcription factors of other CD4 + T cell subsets. We find that AA147-dependent reduction in T H 17 differentiation is independent of ATF6 activation but involves NRF2 activation and reductions in intracellular reactive oxygen species (ROS). Apart from RORγt, we further show that AA147 decreases expression of the TCR-responsive factor IRF4, thus suppressing production of select effector cytokines across effector T cells, revealing additional ways in which this compound reshapes the activities of these essential T cell subsets. Our results demonstrate the potential for metabolically activated proteostasis regulators such as AA147 to selectively reshape T H 17 cell identity while broadly dampening effector cytokine responses across effector T cell subsets.
- Open Access
Maternal antiviral history synergizes with pregnancy and lactation to transfer intergenerational systemic immunity through IgG in milk
Maternal immune transfer is essential for early-life health, yet whether immune experiences before pregnancy shape maternal physiology to optimize immunity in subsequent offspring is unclear. Here, we show that respiratory viral infection before pregnancy confers robust protection against lethal neonatal influenza through antibodies transferred postpartum in milk. Despite the predominance of IgA in milk, antiviral IgG is indispensable for protection. Pregnancy amplifies pre-existing antiviral B cell responses, while prior infection durably reprograms the mammary gland to promote transfer of circulating antiviral IgG into milk. These antibodies retain their epitope specificity, are enriched for broadly protective influenza epitopes, remain functional after passage through the neonatal intestine, and enter offspring circulation through FcRn to provide protection beyond weaning. Natural transmission of virus from infected offspring to mothers establishes maternal immunity that protects future offspring, revealing a coordinated adaptive program that links maternal immune history, pregnancy, and lactation to optimize intergenerational immunity.
Open AccessMaternal antiviral history synergizes with pregnancy and lactation to transfer intergenerational systemic immunity through IgG in milk
Maternal immune transfer is essential for early-life health, yet whether immune experiences before pregnancy shape maternal physiology to optimize immunity in subsequent offspring is unclear. Here, we show that respiratory viral infection before pregnancy confers robust protection against lethal neonatal influenza through antibodies transferred postpartum in milk. Despite the predominance of IgA in milk, antiviral IgG is indispensable for protection. Pregnancy amplifies pre-existing antiviral B cell responses, while prior infection durably reprograms the mammary gland to promote transfer of circulating antiviral IgG into milk. These antibodies retain their epitope specificity, are enriched for broadly protective influenza epitopes, remain functional after passage through the neonatal intestine, and enter offspring circulation through FcRn to provide protection beyond weaning. Natural transmission of virus from infected offspring to mothers establishes maternal immunity that protects future offspring, revealing a coordinated adaptive program that links maternal immune history, pregnancy, and lactation to optimize intergenerational immunity.
- 5 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (111) , eadz6869
Enkephalin-producing regulatory T cells in the skin restrain local inflammation through control of nociception
The skin integrates diverse signals discerned by sensory neurons and immune cells to elicit adaptive responses to a range of stresses. Considering interactions between nervous and immune systems, we examined whether regulatory T (T reg ) cells, which suppress systemic and local inflammation, can modulate activation of peripheral neurons. Acute T reg cell “loss of function” increased neuronal activation to noxious stimuli independently of their immunosuppressive function. This activity was mediated by a T reg cell subset capable of production of enkephalins encoded by the gene Penk , whose expression is facilitated by combined TCR and glucocorticoid receptor signaling. Punctual selective depletion of Penk -expressing T reg cells or specific ablation of Penk in T reg cells increased neuronal activation in response to noxious stimuli and associated inflammation. Our study indicates that a population of tissular T reg cells exhibits neuromodulatory activity to restrain local inflammation in the skin.
- 5 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (111) , eadz6869
Enkephalin-producing regulatory T cells in the skin restrain local inflammation through control of nociception
The skin integrates diverse signals discerned by sensory neurons and immune cells to elicit adaptive responses to a range of stresses. Considering interactions between nervous and immune systems, we examined whether regulatory T (T reg ) cells, which suppress systemic and local inflammation, can modulate activation of peripheral neurons. Acute T reg cell “loss of function” increased neuronal activation to noxious stimuli independently of their immunosuppressive function. This activity was mediated by a T reg cell subset capable of production of enkephalins encoded by the gene Penk , whose expression is facilitated by combined TCR and glucocorticoid receptor signaling. Punctual selective depletion of Penk -expressing T reg cells or specific ablation of Penk in T reg cells increased neuronal activation in response to noxious stimuli and associated inflammation. Our study indicates that a population of tissular T reg cells exhibits neuromodulatory activity to restrain local inflammation in the skin.
- Open Access
- 4 February 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (3) , 444-458
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Regulatory T (Treg) cells are a specialized CD4+ T cell lineage with essential anti-inflammatory functions. Analysis of Treg cell adaptations to non-lymphoid tissues that enable their specialized immunosuppressive and tissue-supportive functions raises questions about the underlying mechanisms of these adaptations and whether they represent stable differentiation or reversible activation states. Here, we characterize distinct colonic effector Treg cell transcriptional programs. Attenuated T cell receptor (TCR) signaling and acquisition of substantial TCR-independent functionality seems to facilitate the terminal differentiation of a population of colonic effector Treg cells that are distinguished by stable expression of the immunomodulatory cytokine IL-10. Functional studies show that this subset of effector Treg cells, but not their expression of IL-10, is indispensable for colonic health. These findings identify core features of the terminal differentiation of effector Treg cells in non-lymphoid tissues and their function.
- 4 February 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (3) , 444-458
Open AccessTerminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Regulatory T (Treg) cells are a specialized CD4+ T cell lineage with essential anti-inflammatory functions. Analysis of Treg cell adaptations to non-lymphoid tissues that enable their specialized immunosuppressive and tissue-supportive functions raises questions about the underlying mechanisms of these adaptations and whether they represent stable differentiation or reversible activation states. Here, we characterize distinct colonic effector Treg cell transcriptional programs. Attenuated T cell receptor (TCR) signaling and acquisition of substantial TCR-independent functionality seems to facilitate the terminal differentiation of a population of colonic effector Treg cells that are distinguished by stable expression of the immunomodulatory cytokine IL-10. Functional studies show that this subset of effector Treg cells, but not their expression of IL-10, is indispensable for colonic health. These findings identify core features of the terminal differentiation of effector Treg cells in non-lymphoid tissues and their function.
- Open Access
- 1 May 2023
- Published by Springer Nature in Nature Immunology
- Vol. 24 (6) , 1020-1035
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies
While regulatory T (Treg) cells are traditionally viewed as professional suppressors of antigen presenting cells and effector T cells in both autoimmunity and cancer, recent findings of distinct Treg cell functions in tissue maintenance suggest that their regulatory purview extends to a wider range of cells and is broader than previously assumed. To elucidate tumoral Treg cell ‘connectivity’ to diverse tumor-supporting accessory cell types, we explored immediate early changes in their single-cell transcriptomes upon punctual Treg cell depletion in experimental lung cancer and injury-induced inflammation. Before any notable T cell activation and inflammation, fibroblasts, endothelial and myeloid cells exhibited pronounced changes in their gene expression in both cancer and injury settings. Factor analysis revealed shared Treg cell-dependent gene programs, foremost, prominent upregulation of VEGF and CCR2 signaling-related genes upon Treg cell deprivation in either setting, as well as in Treg cell-poor versus Treg cell-rich human lung adenocarcinomas. Accordingly, punctual Treg cell depletion combined with short-term VEGF blockade showed markedly improved control of PD-1 blockade-resistant lung adenocarcinoma progression in mice compared to the corresponding monotherapies, highlighting a promising factor-based querying approach to elucidating new rational combination treatments of solid organ cancers.
- 1 May 2023
- Published by Springer Nature in Nature Immunology
- Vol. 24 (6) , 1020-1035
Open AccessConserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies
While regulatory T (Treg) cells are traditionally viewed as professional suppressors of antigen presenting cells and effector T cells in both autoimmunity and cancer, recent findings of distinct Treg cell functions in tissue maintenance suggest that their regulatory purview extends to a wider range of cells and is broader than previously assumed. To elucidate tumoral Treg cell ‘connectivity’ to diverse tumor-supporting accessory cell types, we explored immediate early changes in their single-cell transcriptomes upon punctual Treg cell depletion in experimental lung cancer and injury-induced inflammation. Before any notable T cell activation and inflammation, fibroblasts, endothelial and myeloid cells exhibited pronounced changes in their gene expression in both cancer and injury settings. Factor analysis revealed shared Treg cell-dependent gene programs, foremost, prominent upregulation of VEGF and CCR2 signaling-related genes upon Treg cell deprivation in either setting, as well as in Treg cell-poor versus Treg cell-rich human lung adenocarcinomas. Accordingly, punctual Treg cell depletion combined with short-term VEGF blockade showed markedly improved control of PD-1 blockade-resistant lung adenocarcinoma progression in mice compared to the corresponding monotherapies, highlighting a promising factor-based querying approach to elucidating new rational combination treatments of solid organ cancers.
- Top Cited Papers
Principles of regulatory T cell function
- Open Access
Terminal differentiation and persistence of effector regulatory T cells essential for the prevention of intestinal inflammation
Regulatory T (Treg) cells represent a specialized CD4 + T cell lineage with essential anti-inflammatory functions. Recent studies of the adaptations of Treg cells to non-lymphoid tissues which enable their specialized immunosuppressive and tissue supportive functions raise questions about the underlying mechanisms of these adaptations and whether they represent stable differentiation or reversible activation states. Using novel genetic tools, we characterized the transcriptional programs of distinct colonic effector Treg cell types. We found that attenuated T cell receptor (TCR) signaling and acquisition of substantial TCR independent functionality appears to facilitate the terminal differentiation of a population of colonic effector Treg cells distinguished by stable expression of immunomodulatory cytokine interleukin-10 (IL-10). Functional studies revealed that this subset of effector Treg cells, but not their expression of IL-10, was indispensable for colonic health. These findings suggest core features of terminal differentiation of effector Treg cells in non-lymphoid tissues and their function therein.
Open AccessTerminal differentiation and persistence of effector regulatory T cells essential for the prevention of intestinal inflammation
Regulatory T (Treg) cells represent a specialized CD4 + T cell lineage with essential anti-inflammatory functions. Recent studies of the adaptations of Treg cells to non-lymphoid tissues which enable their specialized immunosuppressive and tissue supportive functions raise questions about the underlying mechanisms of these adaptations and whether they represent stable differentiation or reversible activation states. Using novel genetic tools, we characterized the transcriptional programs of distinct colonic effector Treg cell types. We found that attenuated T cell receptor (TCR) signaling and acquisition of substantial TCR independent functionality appears to facilitate the terminal differentiation of a population of colonic effector Treg cells distinguished by stable expression of immunomodulatory cytokine interleukin-10 (IL-10). Functional studies revealed that this subset of effector Treg cells, but not their expression of IL-10, was indispensable for colonic health. These findings suggest core features of terminal differentiation of effector Treg cells in non-lymphoid tissues and their function therein.
- Open Access
- 21 August 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (11) , 2466-2478
IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus
Regulatory T (T reg) cells, a specialized subset of CD4+ T cells, are essential to prevent fatal autoimmunity. Expression of the T reg lineage-defining transcription factor Foxp3, and therefore their differentiation in the thymus, is dependent upon T cell receptor (TCR) and interleukin-2 (IL-2) signaling. Here, we report that the majority of IL-2–producing cells in the thymus are mature CD4 single-positive (CD4SP) thymocytes and that continuous IL-2 production sustained thymic T reg cell generation and control of systemic immune activation. Furthermore, single-cell RNA sequencing analysis of CD4 thymocyte subsets revealed that IL-2 was expressed in self-reactive CD4SP thymocytes, which also contain T reg precursor cells. Thus, our results suggest that the thymic T reg cell pool size is scaled by a key niche factor, IL-2, produced by self-reactive CD4SP thymocytes. This IL-2–dependent scaling of thymic T reg cell generation by overall self-reactivity of a mature post-selection thymic precursor pool may likely ensure adequate control of autoimmunity.
- 21 August 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (11) , 2466-2478
Open AccessIL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus
Regulatory T (T reg) cells, a specialized subset of CD4+ T cells, are essential to prevent fatal autoimmunity. Expression of the T reg lineage-defining transcription factor Foxp3, and therefore their differentiation in the thymus, is dependent upon T cell receptor (TCR) and interleukin-2 (IL-2) signaling. Here, we report that the majority of IL-2–producing cells in the thymus are mature CD4 single-positive (CD4SP) thymocytes and that continuous IL-2 production sustained thymic T reg cell generation and control of systemic immune activation. Furthermore, single-cell RNA sequencing analysis of CD4 thymocyte subsets revealed that IL-2 was expressed in self-reactive CD4SP thymocytes, which also contain T reg precursor cells. Thus, our results suggest that the thymic T reg cell pool size is scaled by a key niche factor, IL-2, produced by self-reactive CD4SP thymocytes. This IL-2–dependent scaling of thymic T reg cell generation by overall self-reactivity of a mature post-selection thymic precursor pool may likely ensure adequate control of autoimmunity.